Pfizer Inc 2025 SR
The report highlights Pfizer's progress in 2025 toward responsible business growth, sustainable innovation, and health equity. The company reached over 448 million patients with its medicines and vaccines, including expanding its Accord for a Healthier World to 15 participating countries. Pfizer achieved a 40.9% reduction in Scope 1 and 2 greenhouse gas emissions compared to its 2019 baseline, driven by virtual power purchase agreements. Additionally, 72% of its suppliers by spend established science-aligned emissions reduction targets, surpassing its near-term goal.
Company: Pfizer Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: SR
Pages: 77
Back to company
Pfizer Inc
Impact Report
The report highlights Pfizer's progress in 2025 toward responsible business growth, sustainable innovation, and health equity. The company reached over 448 million patients with its medicines and vaccines, including expanding its Accord for a Healthier World to 15 participating countries. Pfizer achieved a 40.9% reduction in Scope 1 and 2 greenhouse gas emissions compared to its 2019 baseline, driven by virtual power purchase agreements. Additionally, 72% of its suppliers by spend established science-aligned emissions reduction targets, surpassing its near-term goal.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target